Connect with us

Health & Wellness

New Study Reveals Breakthrough in Restoring Sense of Smell for Long-COVID Patients

Jaleel Mwangi

Published

on

Recent research presented at the annual meeting of the Radiological Society of North America (RSNA) has brought a beacon of hope for long-COVID patients suffering from parosmia. This new study highlights a pioneering 10-minute treatment that has shown promising results in restoring the sense of smell, a condition that has been affecting a substantial number of COVID-19 survivors.

Understanding Parosmia

  • Parosmia is a distorted sense of smell, a symptom of long-term COVID-19 effects.
  • Up to 60% of COVID-19 patients experience this condition, with many facing prolonged symptoms.
  • Affected individuals often develop a dislike for previously enjoyed foods and drinks, impacting their quality of life.

Impact on Daily Life

The altered sense of smell can significantly affect patients’ dietary preferences and overall enjoyment of life. Phantosmia, where people perceive non-existent odors, is also a related symptom. These olfactory dysfunctions can persist for months or years, making effective treatment a critical need.

Breakthrough Treatment: CT-Guided Stellate Ganglion Block

This innovative procedure involves a CT-guided injection of anesthetic into the stellate ganglion, a part of the autonomic nervous system located in the neck. This method has been used previously for various conditions, but its application for parosmia post-COVID is new.

Key Facts About the Procedure

  • The treatment is minimally invasive and quick, taking less than 10 minutes.
  • It doesn’t require sedation or intravenous analgesia.
  • Involves injecting a combination of anesthetic and a small dose of corticosteroid to address nerve inflammation suspected to be caused by COVID-19.

Study Findings and Results

Conducted by a team led by Adam C. Zoga, M.D., M.B.A., from Jefferson Health, the study involved 54 patients referred by an ear, nose, and throat specialist. These patients had not responded to conventional pharmaceutical and topical therapies.

Encouraging Outcomes

  • The initial patient experienced significant improvement immediately, with continued progress leading to symptom resolution within four weeks.
  • 59% of patients reported improved symptoms within a week of the procedure.
  • 82% of these patients showed significant progressive improvement after one month.
  • A follow-up showed an average of 49% improvement in symptoms, with some patients reporting up to 100% improvement.
  • A second injection on the opposite side of the neck led to further improvement in 86% of the patients who responded positively to the first injection.
  • No complications or adverse events were reported.

Broader Implications

The success of this study not only aids those affected by COVID-19 but also contributes to the broader understanding of treating sensory dysfunctions. This research could pave the way for exploring similar treatments for other conditions related to the autonomic nervous system.

Insights into COVID-19 and Long-Term Effects

The study also offers deeper insights into the long-term effects of COVID-19, emphasizing the need for comprehensive post-recovery care for patients. It highlights the diverse and prolonged impact of the virus, extending beyond the immediate respiratory symptoms.

Future Research and Development

The outcomes look good, but more research is needed to make sure this treatment is safe and works well over time. We need to keep studying it to see how well it works for more types of people and at different points after they’ve had COVID.

Final Thoughts

The study’s success marks a significant step in addressing one of the lingering effects of COVID-19. Continued research and clinical trials are essential to validate these findings further and potentially offer a widely accessible solution to patients worldwide suffering from long-term olfactory dysfunctions due to COVID-19.

The study brings fresh optimism for long-COVID sufferers who are struggling with parosmia. The straightforwardness and success rate of the stellate ganglion block, directed by CT, offer a ray of hope for individuals whose past treatments didn’t work. No complications or negative reactions highlight its possibility as a harmless and efficient therapy. If you want to know more, click on the Radiological Society of North America (RSNA) website.

Jaleel is a sociable and communicative individual who effortlessly builds connections with others. With a strong belief in lending a helping hand, he is always ready to support those in need. Alongside his affinity for new technology, especially smartphones, Jaleel finds pleasure in exploring the latest advancements. When it comes to leisure, he cherishes vacations and finds joy in watching comedic films. With his friendly nature and diverse interests, Jaleel brings positive energy to every interaction and embraces life's enjoyable moments.

Health & Wellness

Measles Outbreak in Florida Raises Public Health Concerns

Cam Speck

Published

on

Florida is dealing with a serious measles outbreak right now. It’s hitting kids in Broward County the hardest and making everyone think hard about public health. People are arguing about vaccines and how to keep folks healthy in Florida because of this problem. 

 Current Outbreak Status

 So far, there are nine people in Florida who got measles. Eight of them are kids in Broward County. We’re talking about tiny tots – one kid is less than five years old and another is between five and nine. And there’s also an adult who got sick in Central Florida’s Polk County, showing this thing is all over the place. People have a lot to say about how Florida’s health leaders are dealing with it, especially how Surgeon General Joseph Ladapo is doing things. He thinks parents should get to decide about their kids getting shots, not just follow what the government says. Not everybody likes that idea, and some health pros from all over are giving him flak for it. That’s happening while more people keep getting sick. Measle cases are on the rise around the world, and this makes it crucial to have strong health policies in place.

Grasping Measles and Its Consequences

Measles spreads easily through coughing, sneezing, or touching things that an infected person has touched. Even though we have a very good MMR vaccine, the illness still threatens those who haven’t been vaccinated.

  • Vaccines are critical- One shot of the MMR vaccine is around 93% effective, while two shots bump that up to 97%.
  • Act fast if exposed- If you think you’ve come into contact with measles, you should get medical advice right away. This might mean getting the MMR vaccine to stop you from getting sick.

The Surgeon General’s Polemic Position

The way Surgeon General Joseph Ladapo has handled the measles situation has caused quite a stir. He focuses on letting parents choose wheather**Ladapo’s Stance Raises Eyebrows**

Amidst debates over public health rules, Ladapo’s suggestions have sparked worry about the possibility of more infections spreading. His view is part of a growing trend to challenge accepted public health actions, which experts say could damage efforts to manage not only measles but other diseases that can be prevented as well.

The choice to not follow advised health measures, like keeping kids without vaccines out of school, has affected the real world. Manatee Bay Elementary School in Weston, at the heart of the outbreak, has seen a notable decrease in students showing up. This shows parents are worried about their kids catching the virus.

Community and Expert Reactions

People in the community have reacted differently. Some parents have decided to keep their children away from school, scared they might catch the virus or as a way to criticize the government’s relaxed approach to health safety. Health specialists across the country have spoken out against this strategy, highlighting the dangers it brings to kids’ wellbeing.

Safety and community wellbeing are at risk. Vaccine expert Dr. Paul Offit points out that when we value personal freedom over group safety, especially with infectious diseases, we’re asking for trouble.

Vaccination rates and public health implications

The recent outbreak has put a spotlight on how many people get vaccinated in the state. In 2022, less than 92% of kindergartners in Broward County got their shots. That’s under the national average and not meeting the CDC’s aim of 95% immunization. Not having enough kids vaccinated is helping the disease to spread, making it clear why we need more people immunized.

Forward Path

The measles outbreak in Florida shows the tough job health officials have when dealing with diseases we can prevent, mainly because some folks are unsure about vaccines and politics get tangled up in it. It shows why sticking to what scientists say is crucial for everyone’s health. Also, it reminds us how vital vaccinations are. Preventing outbreaks requires everyone to work together. It’s important for public health officials, parents, and the whole community to make good choices during this outbreak. Vaccines and following public health rules are key to stop the measles from spreading. These steps protect the health of people living in Florida.

Continue Reading

Health & Wellness

New Hope in Treating Depression and Brain Injury

Anne lise Sylta

Published

on

New medical breakthroughs have researchers excited about testing deep brain stimulation (DBS) as a potential cure for those suffering from serious depression and injuries caused by trauma to the brain. This cutting-edge method, similar to a heart pacemaker but for the brain, requires placing electrodes inside the brain. These electrodes connect to a device under the skin near the chest, sending precise electric jolts to certain areas of the brain.

Deep Brain Stimulation: Pioneering Depression Therapy

DBS is showing encouraging signs in helping people whose depression hasn’t improved with standard treatments. It’s already been okayed for health issues like Parkinson’s and epilepsy. Experts, like those at Mount Sinai West, are optimistic that it might be accessible for depression therapy before too long. A patient named Emily Hollenbeck found that her symptoms got much better quickly after the procedure, saying it was like having “continuous Prozac.”

Tackling Negative Views on Brain Injury

Teams led by Harvard’s Spaulding Rehabilitation Hospital and their colleagues are fighting against the often gloomy expectations for traumatic brain injury recovery. Their work shows that electric stimulation could restart inactive parts of the brain circuits, possibly giving patients back their ability to work and join in social situations. In their studies, they saw boosts in skills like planning, focus, reasoning, and solving problems. Patients even went past what doctors consider a real change for the better just three months into DBS treatment.

How It Works

DBS helps by activating the thalamus, an important part of the brain that sends messages from one area

When electrodes are placed inside the brain, they spark one area, which then activates the thalamus. This wakes up parts of the brain that work fine but just aren’t getting enough signals. Scientists don’t fully get how it works yet, but they think it gets the brain ready to use different networks or smaller systems when necessary.

Overcoming Skepticism

Even though DBS seems promising for treating depression, some doctors are still not sure about it. They’re worried about the risks and don’t quite get how depression affects the brain’s wiring and functions. But, more and more research backs up DBS, and the FDA is speeding up its review for cases where nothing else has helped with depression. These signs point to doctors starting to come around.

The Road Ahead

Scientists keep working on making DBS even more specific for each person, figuring out the best spots in the brain for the electrodes, and maybe mixing it with other treatments to get the best results. Big studies are coming up that could help get FDA approval on the horizon.

Impact on Patients’ Lives

If DBS works out, it’s a big win, not just in medicine but also for people and their families who hope to break free from tough depression and brain injuries. Take Emily Hollenbeck for example; she used to think she’d always be stuck with depression she couldn’t handle, but now small joys make her happy, and she’s optimistic about what’s ahead.

Final Thoughts

The way DBS went from an idea to possibly becoming a common treatment shows why we need to keep digging into brain science. There’s stuff to sort out, but so far, it looks like there might be new ways to help folks who didn’t have much hope before. As more research comes out and people talk about how DBS worked for them, it’s shaping up to be something pretty special.

We’re on the verge of changing how we treat mental health and brain injuries. This shift is about to make a big difference in the field.

Continue Reading

Health & Wellness

FDA Approves First Medication to Combat Severe Cases

Ashley Waithira

Published

on

The U.S. Food and Drug Administration has given the green light to the first-ever treatment aimed at tackling serious frostbite. The drug, iloprost, sold as Aurlumyn, might be a game-changer, possibly keeping millions from facing drastic repercussions of being in the biting cold. Those fearing loss of limbs due to severe frostbite now have a glimmer of hope thanks to this medical breakthrough.

Aurlumyn: A New Dawn in Frostbite Treatment

Frostbite happens when skin and body parts beneath it freeze up, leading to a major cut-off in blood supply. This can cause lasting harm and sometimes force doctors to remove affected limbs. The fresh on the scene Aurlumyn fights this by being a vasodilator—it widens blood vessels and halts blood clots, safeguarding the skin and tissues underneath.

How Aurlumyn Works

  • Vasodilation: Aurlumyn gets blood moving in frostbitten areas by dialing up vessel size, slashing the threat of tissue decay.
  • Clot Prevention: Moreover, it stops blood from getting all clumpy, which is essential for keeping the blood cruising to smaller bits like fingers and toes.

“Having this new option provides physicians with a tool that will help prevent the life-changing amputation of one’s frostbitten fingers or toes,” said Dr. Norman Stockbridge, director of the Division of Cardiology and Nephrology in the FDA’s Center for Drug Evaluation and Research.

Clinical Trials and Efficacy

The thumbs up for Aurlumyn comes on the heels of a clinical trial with 47 adults weathering harsh frostbite. Results showed those dosed with iloprost managed to steer clear from amputations—unlike those given other meds or a mix of treatments including iloprost. This underscores the drug’s standout ability to heal harshly frostbiten folk.

Challenges and Considerations

Aurlumyn looks like it could really change the game when it comes to treating bad cases of frostbite, but it’s not perfect. Taking this medicine may lead to heart flutters, a racing heartbeat, feeling sick, headaches, a red face, throwing up, feeling dizzy, and a drop in blood pressure. This is why it’s super important that a doctor is there to keep an eye on things when someone’s taking it.

Implications for Frostbite Treatment

The rollout of Aurlumyn is a huge deal when it comes to dealing with frostbite. Before, people didn’t have many options, often ending up losing limbs. With Aurlumyn, we’ve got a real shot at not just a better cure but also a deeper understanding of what causes frostbite in the first place.

“It’s groundbreaking, honestly,” says Dr. Peter Hackett, who knows a ton about medicine that helps people when they’re up in mountains or out in the wild. “This is big news for how we take care of frostbite here in the States.”

Looking Ahead: Prevention Still Key

Even with Aurlumyn changing things up, experts still insist staying warm and avoiding frostbite in the first place is best. Wearing the right clothes, having good gear, and knowing what you’re doing are key when you’re out in cold places. Dr. Hackett puts it this way: “Really, stopping frostbite before it starts is what we should be aiming for, not just trying to fix it after.”

To wrap things up, the FDA giving Aurlumyn the thumbs up is big news for folks hit hard by frostbite. It gives them some hope that they won’t have to go through so much pain and loss. But even as we cheer on this new treatment, let’s not forget how vital it is to be smart and prevent frostbite from happening at all.

Continue Reading